SCReN - Publicaciones

Publicaciones de Covid-19

Año publicación	Título	Código	Acrónimo	Tipo	Área
2022	A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of diferent COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network	21.006	EU COVAT Age_1	PROTOCOLO	Covid-19
2022	Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol	21.040	E-SPERANZA COVID	PROTOCOLO	Covid-19
2022	Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial	20.019	SARICOR	RESULTADOS	Covid-19
2022	Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial	20.019	SARICOR	RESULTADOS	Covid-19
2022	Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses	20.017	SOLIDARITY	RESULTADOS	Covid-19
2021	A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia	20.020	Con_Plas 19	RESULTADOS	Covid-19
2021	Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial	20.001	CombiVacs	RESULTADOS	Covid-19
2020	Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial	20.019	SARICOR	PROTOCOLO	Covid-19
2020	Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results	20.017	SOLIDARITY	RESULTADOS	Covid-19